Boston Scientific (BSX)

46.73
+0.73 (1.59%)
NYSE· Last Trade: Aug 1st, 6:10 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close46.00
Open45.84
Bid46.62
Ask46.70
Day's Range44.43 - 46.80
52 Week Range42.20 - 109.50
Volume18,691,891
Market Cap66.54B
PE Ratio (TTM)24.09
EPS (TTM)1.9
Dividend & YieldN/A (N/A)
1 Month Average Volume19,682,919

Chart

About Boston Scientific (BSX)

Boston Scientific is a global medical technology company that specializes in the development, manufacturing, and marketing of a wide range of medical devices and solutions. The company focuses on providing innovative therapies for various medical conditions, including those affecting the cardiovascular, urology, and gastrointestinal systems, among others. Boston Scientific is committed to advancing patient care through its pioneering technologies, which are designed to improve outcomes and enhance the quality of life for patients around the world. Their product offerings include devices for minimally invasive procedures, enabling healthcare professionals to deliver high-quality care efficiently and effectively. Read More

News & Press Releases

BSX Q2 Deep Dive: WATCHMAN and Electrophysiology Challenges Temper Growth Outlook
Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q2 CY2026, with sales up 7.5% year on year to $5.44 billion. On...
Via StockStory · July 30, 2026
Boston Scientific Q2 Earnings Call Highlightsmarketbeat.com
Boston Scientific (NYSE:BSX) reported second-quarter 2026 revenue growth at the high end of its guidance range and adjusted earnings per share above expectations, but lowered its full-year outlook as it faces slowing demand in its WATCHMAN left atrial appendage closure business and increased competi
Via MarketBeat · July 29, 2026
Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session.chartmill.com
Via Chartmill · July 29, 2026
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.chartmill.com
Via Chartmill · July 29, 2026
Boston Scientific (NYSE:BSX) Tops Q2 2026 Estimates on Adjusted EPS Beatchartmill.com
Via Chartmill · July 29, 2026
Boston Scientific Corp (NYSE:BSX) Offers Strong Value with High Profitability and Solid Growthchartmill.com
Via Chartmill · July 6, 2026
Boston Scientific Corp (NYSE:BSX) Meets All Caviar Cruise Quality Criteria for Long-Term Investorschartmill.com
Via Chartmill · June 29, 2026
Get insights into the top movers in the S&P500 index of Wednesday's pre-market session.chartmill.com
Via Chartmill · July 29, 2026
Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations
Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 7.5% year on year to ...
Via StockStory · July 29, 2026
What To Expect From Boston Scientific’s (BSX) Q2 Earnings
Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday morning. Here’s what to expect. Boston Scientific beat analysts...
Via StockStory · July 27, 2026
Here's How Much $100 Invested In Boston Scientific 15 Years Ago Would Be Worth Todaybenzinga.com
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.23% on an annualized basis producing an average annual return of 13.77%. Currently, Boston Scientific has a market capitalization of
Via Benzinga · July 27, 2026
Why Intuitive Surgical’s Strong Quarter Still Spooked Investorsmarketbeat.com
Intuitive Surgical shares fell about 10% after Q2 2026 revenue rose 19% but guidance for da Vinci procedure growth wasn't raised, pushing ISRG below its 200-week moving average.
Via MarketBeat · July 18, 2026
Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings?
Shareholders of Boston Scientific would probably like to forget the past six months even happened. The stock dropped 52.5% and now trades at $42.79. This was...
Via StockStory · July 15, 2026
1 Large-Cap Stock with Exciting Potential and 2 We Turn Down
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it m...
Via StockStory · July 14, 2026
1 Stock Under $50 to Keep an Eye On and 2 We Brush Off
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...
Via StockStory · July 13, 2026
Billionaire Steve Cohen Sold Amazon and Nvidia but Loaded Up on This Beaten-Down Stockfool.com
Steve Cohen, head of Point72 Asset Management, dumped tech stocks and bought this unloved healthcare company.
Via The Motley Fool · July 9, 2026
These S&P500 stocks are moving in today's sessionchartmill.com
Via Chartmill · July 2, 2026
3 Value Stocks to Research Further
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...
Via StockStory · June 29, 2026
2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...
Via StockStory · June 26, 2026
Tuesday's after hours session: top gainers and loserschartmill.com
Via Chartmill · June 23, 2026
Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Yearsbenzinga.com
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.07% on an annualized basis producing an average annual return of 13.28%. Currently, Boston Scientific has a market capitalization of
Via Benzinga · June 23, 2026
Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Monthsfool.com
Analysts remain relatively more upbeat, but this could prove fleeting.
Via The Motley Fool · June 13, 2026
3 S&P 500 Stocks with Solid Fundamentals
The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innova...
Via StockStory · June 2, 2026
Why These Three Big Buybacks Are Sending Very Different Signals to Investorsmarketbeat.com
Quanta Services, Roblox, and Boston Scientific announced share buybacks totaling $6 billion, each under different market conditions and for different strategic reasons.
Via MarketBeat · June 1, 2026
Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
Via StockStory · May 31, 2026